Mary Beth Harler, Chief Executive Officer at IGM Biosciences, Inc. (IGMS), sold 1,708 shares at $7.48 ($13K) on 2024-12-16, disclosed to the SEC on 2024-12-18.
Open-market sale of $13k IGMS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IGMS | SELL | 2025-03-18 | $9K | — | Filing → |
| IGMS | SELL | 2024-09-17 | $17K | — | Filing → |
| IGMS | SELL | 2024-06-18 | $12K | — | Filing → |